- Report
- May 2024
- 138 Pages
Global
From €6195EUR$6,499USD£5,229GBP
- Report
- February 2024
- 175 Pages
Global
From €4766EUR$5,000USD£4,023GBP
- Report
- May 2024
- 185 Pages
Global
From €4671EUR$4,900USD£3,942GBP
- Report
- October 2023
- 180 Pages
Global
From €4671EUR$4,900USD£3,942GBP
- Report
- June 2024
- 200 Pages
Global
From €7578EUR$7,950USD£6,396GBP
- Report
- June 2024
- 200 Pages
Global
From €7578EUR$7,950USD£6,396GBP
- Report
- June 2024
- 200 Pages
Global
From €7578EUR$7,950USD£6,396GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1906EUR$2,000USD£1,609GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1191EUR$1,250USD£1,006GBP
- Drug Pipelines
- January 2024
- 70 Pages
Global
From €1906EUR$2,000USD£1,609GBP
- Clinical Trials
- January 2024
- 90 Pages
Global
From €1430EUR$1,500USD£1,207GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1430EUR$1,500USD£1,207GBP
- Drug Pipelines
- January 2024
- 90 Pages
Global
From €1430EUR$1,500USD£1,207GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1430EUR$1,500USD£1,207GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1430EUR$1,500USD£1,207GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1191EUR$1,250USD£1,006GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1191EUR$1,250USD£1,006GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1191EUR$1,250USD£1,006GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1191EUR$1,250USD£1,006GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1191EUR$1,250USD£1,006GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
The Kinase market is a subset of the Drug Discovery market, focusing on the development of drugs that target kinases, a type of enzyme that plays a role in many cellular processes. Kinase inhibitors are used to treat a variety of diseases, including cancer, diabetes, and neurological disorders. Kinase inhibitors are typically small molecules that bind to the active site of the kinase, blocking its activity.
Kinase inhibitors are developed through a combination of in vitro and in vivo assays, as well as computational modeling. Companies in the Kinase market are focused on developing novel inhibitors that can be used to treat a variety of diseases. These companies include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more